Home › Interstitial Lung Diseases › NCT03478826
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia * Patients willing to provide written informed consent Exclusion Criteria: * Unwillingness/unable to give blood samples
About the study
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
What is being tested
- ILD (other)
- Healthy (other)
- Pneumonia (other)
Sponsor: Mayo Clinic · Participants: 635 · Started: Aug 1, 2018
Contact the study team
- Michael Stachowitz · Phone: 507-284-4862
Official record on ClinicalTrials.gov — NCT03478826
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.